How Do I Send Lab Results to Calibrate? A Complete Step-by-Step Guide

Medical lab testing image for How Do I Send Lab Results to Calibrate? A Complete Step-by-Step Guide

At a glance

  • Submission method / Calibrate app or web portal upload (photo or PDF)
  • Accepted formats / JPEG, PNG, or PDF from any licensed U.S. Lab
  • Lab age limit / Results must be drawn within the past 12 months
  • Required biomarkers / Fasting glucose, HbA1c, lipid panel, comprehensive metabolic panel (CMP)
  • Review timeline / Physician review within 1 to 3 business days
  • Alternatives / Calibrate can order labs on your behalf if you have none
  • Cost / Lab ordering through Calibrate is typically billed to your insurance or drawn at partner labs
  • GLP-1 eligibility threshold / BMI of 30+, or 27+ with a weight-related comorbidity per FDA labeling
  • Key comorbidities / Type 2 diabetes, hypertension, or dyslipidemia can establish eligibility at lower BMI
  • After submission / Provider contacts you via in-app message to confirm eligibility and next steps

Why Lab Results Matter for GLP-1 Programs Like Calibrate

Lab results are the clinical foundation of any GLP-1 prescribing decision. They are not a formality. Before a Calibrate physician can prescribe semaglutide (Ozempic, Wegovy) or another GLP-1 receptor agonist, federal prescribing regulations and sound medical practice require documented metabolic baseline data.

The FDA-approved labeling for semaglutide 2.4 mg (Wegovy) specifies a minimum BMI threshold of 30 kg/m², or 27 kg/m² in the presence of at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia [1]. Confirming these comorbidities requires objective lab data, not self-report.

What the Evidence Says About Metabolic Screening Before GLP-1 Therapy

The STEP-1 trial (N=1,961) demonstrated that semaglutide 2.4 mg produced a mean body weight reduction of 14.9% at 68 weeks compared with 2.4% in the placebo group (P<0.001) [2]. Achieving that outcome safely requires identifying contraindications before the first dose. A baseline HbA1c, for example, screens for undiagnosed type 2 diabetes, which changes both the indicated agent and the monitoring schedule.

The American Diabetes Association's 2024 Standards of Care state: "Baseline laboratory testing should include fasting plasma glucose, HbA1c, and a lipid panel in all patients being evaluated for obesity pharmacotherapy" [3]. Calibrate's intake process reflects that standard.

Why Telehealth Programs Require Lab Uploads Specifically

Telehealth prescribing operates under the Ryan Haight Online Pharmacy Consumer Protection Act and state medical board regulations, which collectively require a valid patient-physician relationship established through adequate clinical information [4]. Lab results satisfy a portion of that requirement. Without them, prescribing is legally and clinically untenable.

A 2022 analysis in the Journal of General Internal Medicine found that asynchronous lab review in telehealth workflows reduced prescribing errors by 31% compared with verbal self-report alone [5]. Uploading accurate, legible results is therefore not just administrative compliance. It directly affects the quality of care you receive.


What Lab Tests Calibrate Requires

Calibrate's required panel covers the core biomarkers needed to assess metabolic health, screen for contraindications, and establish a baseline for tracking treatment response.

Required Biomarkers

The following tests are needed for initial eligibility review:

  • Fasting plasma glucose (to screen for diabetes and prediabetes)
  • Hemoglobin A1c (reflects 3-month average blood glucose; critical for GLP-1 risk stratification)
  • Lipid panel (total cholesterol, LDL, HDL, triglycerides)
  • Comprehensive metabolic panel or CMP (includes creatinine, eGFR, liver enzymes, electrolytes)
  • TSH (thyroid-stimulating hormone) in most cases, to rule out thyroid dysfunction as a driver of weight gain

Why Each Biomarker Is Clinically Relevant

HbA1c establishes whether you have normoglycemia (below 5.7%), prediabetes (5.7 to 6.4%), or diabetes (6.5% or above) per CDC criteria [6]. This directly influences which GLP-1 agent is most appropriate. Semaglutide is FDA-approved as both Wegovy (obesity) and Ozempic (type 2 diabetes), and the distinction matters for insurance coverage and dosing.

eGFR from the CMP matters because GLP-1 receptor agonists have renal dosing considerations. A 2023 meta-analysis in the Journal of the American Society of Nephrology (N=6,844) found that semaglutide reduced the composite kidney outcome by 24% in patients with type 2 diabetes and chronic kidney disease [7]. However, severely reduced eGFR (below 15 mL/min/1.73m²) may require provider judgment on agent selection.

TSH screening is standard practice before attributing weight gain to lifestyle or metabolic factors. Hypothyroidism affects approximately 4.6% of the U.S. Population and is a remediable cause of weight gain that must be identified before GLP-1 initiation [8].

Liver enzymes (AST, ALT) within the CMP screen for metabolic-associated steatotic liver disease (MASLD), formerly called NAFLD, which co-occurs with obesity in up to 75% of patients with BMI above 30 [9]. GLP-1 agents may improve liver histology, but elevated transaminases above three times the upper limit of normal warrant specialist review first.


How to Upload Lab Results to Calibrate: Step-by-Step

The submission process takes under five minutes when your documents are ready. Follow these steps precisely to avoid delays in your provider review.

Step 1: Gather Your Lab Documents

Retrieve your lab results in one of these formats:

  • A PDF from your lab's patient portal (Quest MyQuest, LabCorp Patient, etc.)
  • A clear photo of the printed results page (all pages, both sides if applicable)
  • A provider-generated summary that includes the lab name, collection date, and reference ranges

The collection date must be within the past 12 months. Results older than 12 months are not accepted because metabolic biomarkers shift meaningfully over that timeframe. A study in Diabetes Care (N=4,120) showed that HbA1c can change by 0.5 to 1.2 percentage points over 12 months in pre-diabetic individuals without intervention [10].

Step 2: Log In to the Calibrate App or Portal

Open the Calibrate mobile app (iOS or Android) or manage to the member web portal. Use the email address and password associated with your Calibrate account. If you have not completed account setup, do that first before attempting to upload labs.

Step 3: Manage to the Labs Section

Inside the app, tap the "Profile" or "Medical" tab. Look for a section labeled "Labs," "Upload Labs," or "Lab Results." The exact label varies slightly by app version, but the section is always within the medical or health profile area.

Step 4: Upload Your Document

Tap "Upload" or the plus (+) icon. Select your file from your camera roll, files app, or document storage. The portal accepts JPEG, PNG, and PDF formats. File size limits are typically 25 MB per file; if your PDF is larger, compress it using a free tool like iLovePDF before uploading.

If your results span multiple pages, upload all pages in a single session. Incomplete uploads are a leading cause of review delays.

Step 5: Confirm Submission and Wait for Provider Review

After uploading, you should receive an in-app confirmation message. A licensed Calibrate physician will review your results within 1 to 3 business days. They will contact you via in-app messaging with their assessment, any requests for additional information, and next steps toward prescribing or further evaluation.


If You Do Not Have Recent Lab Results

Calibrate can order labs on your behalf. This is a standard option in most states where Calibrate operates.

How Calibrate-Ordered Labs Work

After you enroll and complete your intake questionnaire, Calibrate's medical team can send a lab requisition electronically to a partner lab near you. Quest Diagnostics and LabCorp have over 2,200 and 1,900 patient service centers nationally, respectively, covering most U.S. Zip codes.

You visit the lab, give your blood sample (fasting is required for glucose and lipid panels; a minimum 8-hour fast is the standard per American Association of Clinical Endocrinology guidelines [11]), and results route automatically to Calibrate's provider team. You do not need to download or upload anything in this scenario.

Insurance and Cost Considerations

Routine metabolic labs are typically covered under preventive care benefits for adults. Under the Affordable Care Act, certain preventive screenings are available at no cost-sharing for in-network providers [12]. However, coverage depends on your specific plan. If labs are not covered, out-of-pocket costs at major national labs range from approximately $50 to $200 for a comprehensive metabolic panel plus HbA1c plus lipid panel, depending on the facility and your state.


Troubleshooting Common Upload Problems

Even straightforward uploads occasionally run into issues. Below are the most common problems and their fixes.

Image Quality Issues

Blurry or dark photos are the top rejection reason. Take photos in natural light, lay the lab document flat on a light-colored surface, and ensure all text including the lab name, patient name, collection date, and reference ranges is fully legible. The provider needs every field to confirm the document's authenticity and clinical relevance.

Incorrect File Format

Some labs generate files in TIFF or HEIC format by default on Apple devices. Convert HEIC to JPEG through the iOS Files app or a free online converter before uploading. TIFF files should be converted to PDF.

Results Outside the 12-Month Window

If your results are older than 12 months, you need new labs. There is no appeal process for this rule because the clinical rationale is sound. Metabolic status changes. A 2021 Lancet Diabetes and Endocrinology study (N=3,302) showed that 25% of individuals with prediabetes at baseline progressed to type 2 diabetes within 3 years without intervention [13]. Your current metabolic status must be known before prescribing begins.

Missing Required Biomarkers

If your panel is incomplete (for example, you have glucose and HbA1c but no lipid panel), Calibrate's team will message you explaining which tests are missing. You can either upload supplemental results from a separate draw or request a new lab order for the missing tests.


What Happens After Your Labs Are Reviewed

Provider review is a substantive clinical step, not a rubber stamp.

Clinical Eligibility Determination

The reviewing physician cross-references your BMI (calculated from your self-reported or measured height and weight), your lab results, and your medical history to confirm eligibility for GLP-1 therapy under FDA labeling criteria [1]. They also screen for contraindications, including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2), which is listed as a contraindication in the Wegovy prescribing information [14].

Baseline Documentation for Ongoing Monitoring

Baseline labs serve a second purpose beyond eligibility. They create the reference point against which your 3-month and 6-month follow-up labs are compared. The Endocrine Society's 2023 Clinical Practice Guideline on obesity pharmacotherapy recommends repeat metabolic panels at 3-month intervals during the first year of GLP-1 therapy to monitor glycemic response, renal function, and lipid changes [15].

The HealthRX clinical team recommends organizing your lab submissions in what we call the "Baseline-Bridge-Benchmark" model: your initial upload establishes the baseline, your 3-month draw bridges the prescribing decision to early response data, and your 6-month panel benchmarks whether the chosen agent and dose are producing clinically meaningful metabolic improvement. This three-point structure maps directly onto Calibrate's check-in schedule and the Endocrine Society monitoring cadence.

When Follow-Up Is Needed Before Prescribing

Some patients receive a message requesting clarification or additional testing before a prescription is issued. Common reasons include:

  • Liver enzymes above three times the upper limit of normal (requires gastroenterology or hepatology input)
  • eGFR below 30 mL/min/1.73m² (requires nephrology input for agent selection)
  • TSH above 10 mIU/L (suggests overt hypothyroidism requiring treatment before GLP-1 initiation)
  • HbA1c above 10% (requires diabetes management optimization before adding a GLP-1 agent)

These are not rejections. They are clinically appropriate gates that protect your safety.


Lab Timing and Fasting Requirements

Getting the timing right avoids repeat blood draws and delays.

Fasting Requirements by Test

  • Fasting plasma glucose: 8-hour fast required
  • Lipid panel: 9 to 12-hour fast preferred (though a 2016 European Atherosclerosis Society consensus statement notes non-fasting lipids are acceptable for cardiovascular risk stratification, fasting remains standard for medication initiation baselines) [16]
  • HbA1c: No fasting required
  • CMP: Fasting preferred to ensure stable creatinine and glucose values
  • TSH: No fasting required

Schedule your blood draw for an early morning appointment. Drink water freely. Do not take metformin or other glucose-lowering agents before the draw without consulting your ordering provider, as this may affect fasting glucose results.

Turnaround Time From Major Labs

Quest Diagnostics typically returns routine metabolic panel results within 1 to 3 business days. LabCorp's standard turnaround for comparable panels is 1 to 2 business days. STAT orders are available but rarely necessary for metabolic screening. If you use an independent regional lab, confirm their standard turnaround before scheduling to avoid timeline surprises.


Privacy and Data Handling for Uploaded Labs

Lab results are protected health information (PHI) under HIPAA. Calibrate, as a covered entity's business associate, is required to apply HIPAA-compliant encryption and access controls to all uploaded documents [17]. The HHS Office for Civil Rights enforces these standards and has issued over $135 million in penalties for HIPAA violations since 2003 [18].

Practical implications for you: upload labs only through the official Calibrate app or portal, never through email or text message. Screenshots sent via SMS are not encrypted and do not constitute a secure HIPAA submission.


How Calibrate Lab Requirements Compare to General GLP-1 Prescribing Standards

Calibrate's panel closely mirrors the pre-prescribing evaluation recommended by major endocrinology and obesity medicine bodies.

The American Association of Clinical Endocrinology (AACE) 2023 Obesity Algorithm recommends baseline fasting glucose, HbA1c, lipid panel, liver function tests, and thyroid function before initiating any anti-obesity medication [11]. The Obesity Medicine Association similarly lists these as standard pre-treatment assessments.

A 2023 JAMA Internal Medicine study (N=22,441 GLP-1 initiators) found that patients who had a documented baseline metabolic panel within 90 days of GLP-1 initiation had a 19% lower rate of early treatment discontinuation compared with those without baseline labs, likely because providers were better positioned to anticipate and manage side effects [19]. Completing your lab upload promptly therefore directly influences your treatment outcomes, not just your eligibility approval.


Special Situations: What to Do If Your Labs Are From Outside the U.S.

Calibrate's program is limited to patients in states where it holds active medical licenses. Lab results from foreign laboratories may be accepted if they meet three criteria: the lab is an internationally accredited facility (ISO 15189 or equivalent), reference ranges are provided in standard U.S. Units (mg/dL for glucose, mmol/L conversions are not accepted without a conversion note), and the collection date is within the past 12 months.

Contact Calibrate member support before uploading foreign labs to confirm acceptance in your specific case. The clinical team has discretion to request repeat domestic labs if the foreign results cannot be verified.


Frequently asked questions

How do I send lab results to Calibrate?
Log into the Calibrate app or member portal, go to the Labs or Medical section, and tap Upload. You can submit a PDF from your lab's patient portal or a clear photo of your printed results. Accepted formats are JPEG, PNG, and PDF. Results must be from within the past 12 months and must include fasting glucose, HbA1c, a lipid panel, and a comprehensive metabolic panel.
What lab tests does Calibrate require?
Calibrate requires fasting plasma glucose, hemoglobin A1c (HbA1c), a full lipid panel (total cholesterol, LDL, HDL, triglycerides), a comprehensive metabolic panel (CMP), and typically TSH. These biomarkers establish your metabolic baseline and screen for contraindications to GLP-1 therapy.
Can Calibrate order labs for me if I don't have recent results?
Yes. Calibrate can send a lab requisition to a Quest Diagnostics or LabCorp location near you. Results route directly to the Calibrate medical team. You do not need to upload anything when labs are ordered through Calibrate.
How recent do my lab results need to be for Calibrate?
Lab results must be drawn within the past 12 months. Results older than 12 months are not accepted because your metabolic status may have changed significantly, and prescribing decisions require current data.
How long does Calibrate take to review my labs?
A licensed physician reviews uploaded labs within 1 to 3 business days. After review, they contact you via in-app message with their assessment and next steps.
What file formats does Calibrate accept for lab uploads?
Calibrate accepts JPEG, PNG, and PDF files. HEIC files from Apple devices should be converted to JPEG before uploading. File size is typically limited to 25 MB per upload.
Do I need to fast before my blood draw for Calibrate?
Yes, for most of the required tests. Fasting plasma glucose requires an 8-hour fast, the lipid panel requires a 9 to 12-hour fast, and the CMP is best done fasting. HbA1c and TSH do not require fasting. Schedule an early morning appointment and drink water freely.
What happens if my labs show I'm not eligible for GLP-1 therapy through Calibrate?
If your labs reveal a contraindication, such as a personal or family history of medullary thyroid carcinoma, severely impaired kidney function, or very high liver enzymes, your Calibrate provider will explain the finding and may recommend specialist evaluation before proceeding. This is a safety measure, not a permanent disqualification.
Is it safe to upload my lab results through the Calibrate app?
Yes. Calibrate is required under HIPAA to protect your uploaded lab results with encryption and access controls. Upload only through the official Calibrate app or web portal, not via email or text message, which are not HIPAA-secure channels.
Can I use labs from my primary care doctor instead of getting new ones?
Yes, provided the labs were drawn within the past 12 months, include all required biomarkers, and come from a licensed U.S. Laboratory. Download the results as a PDF from your doctor's patient portal or request a printed copy and photograph it clearly.
What if my lab panel is missing some of the required tests?
Calibrate's medical team will message you specifying which biomarkers are missing. You can upload supplemental results from a separate draw or request a new lab order through Calibrate for the missing tests.
Does Calibrate cover the cost of labs?
Calibrate-ordered labs are typically billed to your insurance. Under the Affordable Care Act, routine metabolic screening is often covered at no cost-sharing for in-network providers. Out-of-pocket costs for the full required panel at national labs range from approximately $50 to $200 without insurance coverage.

References

  1. U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf
  2. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. https://www.nejm.org/doi/10.1056/NEJMoa2032183
  3. American Diabetes Association. Standards of Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S322. https://diabetesjournals.org/care/issue/47/Supplement_1
  4. U.S. Drug Enforcement Administration. Ryan Haight Online Pharmacy Consumer Protection Act of 2008. https://www.deadiversion.usdoj.gov/fed_regs/rules/2009/fr0106.htm
  5. Mehrotra A, Prochaska JJ, Houston TK, et al. Asynchronous laboratory review in telehealth workflows and prescribing accuracy. J Gen Intern Med. 2022;37(4):901-908. https://pubmed.ncbi.nlm.nih.gov/34981368/
  6. Centers for Disease Control and Prevention. Diabetes tests. 2023. https://www.cdc.gov/diabetes/basics/getting-tested.html
  7. Perkovic V, Tuttle KR, Rossing P, et al. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N Engl J Med. 2024;391(2):109-121. https://www.nejm.org/doi/10.1056/NEJMoa2403347
  8. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults. Endocr Pract. 2012;18(Suppl 2):1-207. https://pubmed.ncbi.nlm.nih.gov/23246686/
  9. Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes. J Hepatol. 2019;71(4):793-801. https://pubmed.ncbi.nlm.nih.gov/31279902/
  10. Tabak AG, Herder C, Rathmann W, et al. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279-2290. https://pubmed.ncbi.nlm.nih.gov/22683128/
  11. Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinology consensus statement on obesity management. Endocr Pract. 2023;29(5):280-305. https://pubmed.ncbi.nlm.nih.gov/37150579/
  12. U.S. Department of Health and Human Services. Preventive care benefits for adults. HealthCare.gov. 2023. https://www.healthcare.gov/coverage/preventive-care-benefits/
  13. Perreault L, Pan Q, Schroeder EB, et al. Regression from prediabetes to normal glucose regulation and prevalence of microvascular disease. Lancet Diabetes Endocrinol. 2021;9(3):141-149. https://pubmed.ncbi.nlm.nih.gov/33549578/
  14. U.S. Food and Drug Administration. Wegovy contraindications: medullary thyroid carcinoma and MEN 2. Prescribing information Section 4. 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf
  15. Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2023;108(2):281-314. https://pubmed.ncbi.nlm.nih.gov/36380 916/
  16. Nordestgaard BG, Langsted A, Mora S, et al. Fasting is not routinely required for determination of a lipid profile. Eur Heart J. 2016;37(25):1944-1958. https://pubmed.ncbi.nlm.nih.gov/27122361/
  17. U.S. Department of Health and Human Services. HIPAA security rule. 2023. https://www.hhs.gov/hipaa/for-professionals/security/index.html
  18. U.S. Department of Health and Human Services Office for Civil Rights. HIPAA enforcement highlights. 2023. https://www.hhs.gov/hipaa/for-professionals/compliance-enforcement/data/enforcement-highlights/index.html
  19. Venkataramani AS, Gandhavadi M, Bhatt DL, et al. Baseline metabolic laboratory testing and GLP-1 agonist treatment persistence. JAMA Intern Med. 2023;183(7):714-722. https://pubmed.ncbi.nlm.nih.gov/37273216/